相关实验视频

Updated: Jun 7, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

CAT rs1001179 单核酸多态性识别了慢性淋巴细胞白血病中的侵略性临床行为

Marilisa Galasso¹, Vittoria Salaorni², Riccardo Moia³

¹Department of Engineering for Innovation Medicine, Section of Biomedicine, University of Verona, Verona, Italy.

Hematological oncology

|November 14, 2024

概括

催化酶 (CAT) 基因促进者的TT基因型与慢性淋巴细胞白血病 (CLL) 患者的更快临床进展有关. 这种遗传标记可能会改善风险分层,并个性化治疗CLL.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
血液学血液学血液学

背景情况:

慢性淋巴细胞白血病 (CLL) 呈现出显著的临床异质性,尽管已建立的预后标志物.
高触酶 (CAT) 表达与攻击性CLL相关,与CAT促进体中的rs1001179 SNP T等位基因相关.

研究的目的:

在慢性淋巴细胞白血病 (CLL) 中研究CAT rs1001179单核酸多态 (SNP) 的预后价值.
确定CAT rs1001179 SNP是否可以完善风险分层,并为CLL患者个性化治疗选择.

主要方法:

在两个独立的CLL患者队列中,CAT rs1001179 SNP的基因定型 (n=235探索性,n=531验证).
进行了时间到事件建模分析,以评估时间到第一次治疗 (TTFT).
进行统计分析以评估SNP与其他预后参数的独立性.

主要成果:

CAT rs1001179 SNP的TT基因型与CLL患者较短的TTFT显著相关.
这种关联与CLL的确定的预后因素保持独立.
TT基因型识别了具有更快临床进展的患者,即使在低风险子组内也是如此.

结论:

CAT rs1001179 SNP的TT基因型是CLL中较短的TTFT的潜在预后因素.
这种SNP可以增强风险分层,从而改善患者管理和个性化的CLL治疗策略.

关键词:

催化酶的催化剂是什么慢性淋巴细胞白血病慢性淋巴细胞白血病单个核酸的多态性.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...